Home › Transthyretin-Related Hereditary Amyloidosis › Oregon › Portland
Transthyretin-Related Hereditary Amyloidosis clinical trials in Portland, OR
4 studies for Transthyretin-Related Hereditary Amyloidosis are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
RecruitingObservational study
- Research Site, Portland
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- Oregon Health & Science University, Portland
Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
RecruitingPhase 2
- Oregon Health & Science University, Portland
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
RecruitingPhase 3
- Oregon Health and Science University (OHSU), Portland
Transthyretin-Related Hereditary Amyloidosis trials in other cities
- New York City, NY5 studies
- Los Angeles, CA5 studies
- San Diego, CA4 studies
- Baltimore, MD4 studies
- Philadelphia, PA4 studies
- Dallas, TX4 studies
- Boston, MA4 studies
- Durham, NC4 studies
- New Haven, CT3 studies
- Richmond, VA3 studies
- Washington, DC3 studies
- Rochester, MN3 studies
Other studies in Portland
- Non-Small Cell Lung Cancer46 studies
- Cancer (all types)34 studies
- Breast Cancer33 studies
- Prostate Cancer33 studies
- Metastatic Cancer29 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Lung Cancer26 studies
- Acute Myeloid Leukemia25 studies
- Endometrial Cancer24 studies
- Head and Neck Squamous Cell Carcinoma19 studies
- Pancreatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.